Review suggests the middle-aged brain could provide a window into future cognitive health

The middle-aged brain could provide a window into future cognitive health, researchers write in a review publishing March 19 in the journal Trends in Neurosciences.

Pressure from anti-China legislation begins to ripple through biopharma

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 13, 2024

Signal: AbbVie ends multi-million dollar cancer drug deal with I-Mab – Pharmaceutical Technology

Biopharmaceuticals company AbbVie have pulled out of their deal with I-Mab. Photo: Valeriya Zankovych / Shutterstock.com. Biopharma giant AbbVie has announced it intends to terminate

September 25, 2023

Pharmalittle: Bluebird claims big insurer will cover its sickle cell therapy; House Republicans threaten to subpoena FDA commish

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

December 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.